Bumgardner, J. D., Adatrow, P., Haggard, W. O., and Norowski, P. A.:
Emerging antibacterial biomaterial strategies for the prevention of
peri-implant inflammatory diseases, Int. J. Oral Maxillofac. Implants, 26,
553–560, 2011.
Capuano, N., Logoluso, N., Gallazzi, E., Drago, L., and Romanò, C. L.:
One-stage exchange with antibacterial hydrogel coated implants provides
similar results to two-stage revision, without the coating, for the
treatment of peri-prosthetic infection, Knee Surgery, Sport. Traumatol.
Arthrosc., 26, 3362–3367, https://doi.org/10.1007/s00167-018-4896-4, 2018.
Cobo, J. and Del Pozo, J. L.: Prosthetic joint infection: diagnosis and
management., Expert Rev. Anti. Infect. Ther., 9, 787–802,
https://doi.org/10.1586/eri.11.95, 2011.
Fiore, M., Sambri, A., Zucchini, R., Giannini, C., Donati, D. M., and De
Paolis, M.: Silver-coated megaprosthesis in prevention and treatment of
peri-prosthetic infections: a systematic review and meta-analysis about
efficacy and toxicity in primary and revision surgery, Eur. J. Orthop. Surg.
Traumatol., 31, 201–220, https://doi.org/10.1007/s00590-020-02779-z, 2021.
Gallo, J., Panacek, A., Prucek, R., Kriegova, E., Hradilova, S., Hobza, M.,
and Holinka, M.: Silver Nanocoating Technology in the Prevention of
Prosthetic Joint Infection, Mater. (Basel, Switzerland), 9, 337,
https://doi.org/10.3390/ma9050337, 2016.
Gundtoft, P. H., Pedersen, A. B., Varnum, C., and Overgaard, S.: Increased
Mortality After Prosthetic Joint Infection in Primary THA, Clin. Orthop.
Relat. Res., 475, 2623–2631, https://doi.org/10.1007/s11999-017-5289-6,
2017.
Holleyman, R. J., Baker, P., Charlett, A., Gould, K., and Deehan, D. J.:
Microorganisms responsible for periprosthetic knee infections in England and
Wales, Knee Surg. Sports Traumatol. Arthrosc., 24, 3080–3087,
https://doi.org/10.1007/s00167-015-3539-2, 2016.
Kapadia, B. H., Berg, R. A., Daley, J. A., Fritz, J., Bhave, A., and Mont,
M. A.: Periprosthetic joint infection, Lancet, 387, 386–394,
https://doi.org/10.1016/S0140-6736(14)61798-0, 2016.
Kunutsor, S. K., Whitehouse, M. R., Blom, A. W., Beswick, A. D., Strange,
S., Garfield, K., Lenguerrand, E., Gooberman-Hill, R., Moore, D., Burston,
A., Simon, J., King, G., Wylde, V., Noble, S., Lane, A., Carroll, F., Webb,
J., MacGowan, A., Jones, S., Taylor, A., Dieppe, P., Toms, A., Wilson, M.,
Stockley, I., Burston, B., Whittaker, J. P., and Board, T.: Re-infection
outcomes following one- and two-stage surgical revision of infected hip
prosthesis: A systematic review and meta-analysis, PLoS One, 10, 1–14,
https://doi.org/10.1371/journal.pone.0139166, 2015.
Lamagni, T.: Epidemiology and burden of prosthetic joint infections, J.
Antimicrob. Chemother., 69, 5–10, https://doi.org/10.1093/jac/dku247, 2014.
Lamret, F., Colin, M., Mongaret, C., Gangloff, S. C., and Reffuveille, F.:
Antibiotic tolerance of
Staphylococcus aureus biofilm in periprosthetic
joint infections and antibiofilm strategies, Antibiotics, 9, 547,
https://doi.org/10.3390/antibiotics9090547, 2020.
Li, C., Renz, N., and Trampuz, A.: Management of Periprosthetic Joint
Infection, Hip Pelvis, 30, 138–146,
https://doi.org/10.5371/hp.2018.30.3.138, 2018.
Mahamuni-Badiger, P. P., Patil, P. M., Badiger, M. V., Patel, P. R.,
Thorat-Gadgil, B. S., Pandit, A., and Bohara, R. A.: Biofilm formation to
inhibition: Role of zinc oxide-based nanoparticles, Mat. Sci. Eng. C-Biomim., 108, 110319,
https://doi.org/10.1016/j.msec.2019.110319, 2020.
Meftah, S., Belhaj, K., Zahi, S., Mahir, L., lmidmani, F., and El Fatimi,
A.: Comparison of functional outcomes and quality of life after THA
according to indication about 210 THA, Ann. Phys. Rehabil. Med., 59, e111,
https://doi.org/10.1016/j.rehab.2016.07.247, 2016.
Minassian, A. M., Osmon, D. R., and Berendt, A. R.: Clinical guidelines in
the management of prosthetic joint infection, J. Antimicrob. Chemother., 69,
29–35, https://doi.org/10.1093/jac/dku253, 2014.
Miwa, S., Shirai, T., Yamamoto, N., Hayashi, K., Takeuchi, A., Tada, K.,
Kajino, Y., Higuchi, T., Abe, K., Aiba, H., Taniguchi, Y., and Tsuchiya, H.:
Risk factors for surgical site infection after malignant bone tumor
resection and reconstruction 11 Medical and Health Sciences 1103 Clinical
Sciences, BMC Cancer, 19, 33, https://doi.org/10.1186/s12885-019-5270-8,
2019.
Nair, R., Schweizer, M. L., and Singh, N.: Septic Arthritis and Prosthetic
Joint Infections in Older Adults, Infect. Dis. Clin. North Am., 31,
715–729, https://doi.org/10.1016/j.idc.2017.07.013, 2017.
Osmon, D. R., Berbari, E. F., Berendt, A. R., Lew, D., Zimmerli, W.,
Steckelberg, J. M., Rao, N., Hanssen, A., and Wilson, W. R.: Diagnosis and
management of prosthetic joint infection: clinical practice guidelines by
the Infectious Diseases Society of America., Clin. Infect. Dis. an Off.
Publ. Infect. Dis. Soc. Am., 56, e1–e25,
https://doi.org/10.1093/cid/cis803, 2013.
Parry, M. C., Laitinen, M. K., Albergo, J. I., Gaston, C. L., Stevenson, J.
D., Grimer, R. J., and Jeys, L. M.: Silver-coated (Agluna
®)
tumour prostheses can be a protective factor against infection in high risk
failure patients, Eur. J. Surg. Oncol., 45, 704–710,
https://doi.org/10.1016/j.ejso.2018.12.009, 2019.
Parvizi, J., Tan, T. L., Goswami, K., Higuera, C., Della Valle, C., Chen, A.
F., and Shohat, N.: The 2018 Definition of Periprosthetic Hip and Knee
Infection: An Evidence-Based and Validated Criteria, J. Arthroplasty, 33,
1309–1314.E2, https://doi.org/10.1016/j.arth.2018.02.078, 2018.
Reina, N., Delaunay, C., Chiron, P., Ramdane, N., and Hamadouche, M.:
Infection as a cause of primary total hip arthroplasty revision and its
predictive factors, Orthop. Traumatol. Surg. Res., 99, 555–561,
https://doi.org/10.1016/j.otsr.2013.07.001, 2013.
Romanò, C. L., Scarponi, S., Gallazzi, E., Romanò, D., and Drago,
L.: Antibacterial coating of implants in orthopaedics and trauma: A
classification proposal in an evolving panorama, J. Orthop. Surg. Res., 10,
157, https://doi.org/10.1186/s13018-015-0294-5, 2015.
Romanò, C. L., Malizos, K., Capuano, N., Mezzoprete, R., D'Arienzo, M., Der, C. V., Scarponi, S., and Drago, L.: Does an Antibiotic-Loaded Hydrogel Coating Reduce Early Post-Surgical Infection After Joint Arthroplasty?, J. Bone Joint Infect., 1, 34–41, https://doi.org/10.7150/jbji.15986, 2016.
Sambri, A., Bianchi, G., Parry, M., Frenos, F., Campanacci, D., Donati, D.,
and Jeys, L.: Is Arthrodesis a Reliable Salvage Option following Two-Stage
Revision for Suspected Infection in Proximal Tibial Replacements? A
Multi-Institutional Study, J. Knee Surg., 32, 911–918,
https://doi.org/10.1055/s-0038-1672121, 2019.
Sebastian, S., Liu, Y., Christensen, R., Raina, D. B., Tägil, M., and
Lidgren, L.: Antibiotic containing bone cement in prevention of hip and knee
prosthetic joint infections: A systematic review and meta-analysis, J.
Orthop. Transl., 23, 53–60, https://doi.org/10.1016/j.jot.2020.04.005,
2020.
Streitbuerger, A., Henrichs, M. P., Hauschild, G., Nottrott, M., Guder, W.,
and Hardes, J.: Silver-coated megaprostheses in the proximal femur in
patients with sarcoma, Eur. J. Orthop. Surg. Traumatol., 29, 79–85,
https://doi.org/10.1007/s00590-018-2270-3, 2019.
Tubb, C. C., Polkowksi, G. G., and Krause, B.: Diagnosis and Prevention of
Periprosthetic Joint Infections, J. Am. Acad. Orthop. Surg., 28, E340–E348,
https://doi.org/10.5435/JAAOS-D-19-00405, 2020.
Tzeng, A., Tzeng, T. H., Vasdev, S., Korth, K., Healey, T., Parvizi, J., and
Saleh, K. J.: Treating periprosthetic joint infections as biofilms: Key
diagnosis and management strategies, Diagn. Microbiol. Infect. Dis., 81,
192–200, https://doi.org/10.1016/j.diagmicrobio.2014.08.018, 2015.
Vaz, K., Scarborough, M., Bottomley, N., Kendrick, B., Taylor, A., Price,
A., Alvand, A., and Jackson, W.: Debridement, antibiotics and implant
retention (DAIR) for the management of knee prosthetic joint infection,
Knee, 27, 2013–2015, https://doi.org/10.1016/j.knee.2020.08.011, 2020.
Wafa, H., Grimer, R. J., Reddy, K., Jeys, L., Abudu, A., Carter, S. R., and
Tillman, R. M.: Retrospective evaluation of the incidence of early
periprosthetic infection with silver-treated endoprostheses in high-risk
patients: Case-control study, Bone Jt. J., 97-B, 252–257,
https://doi.org/10.1302/0301-620X.97B2.34554, 2015.
Wengler, A., Nimptsch, U., and Mansky, T.: Hüft- und kniegelenkersatz in
Deutschland und den USA: Auswertung deutscher und us-amerikanischer
krankenhauseinzelfalldaten von 2005 bis 2011, Dtsch. Arztebl. Int., 111,
407–416, https://doi.org/10.3238/arztebl.2014.0407, 2014.
Wetters, N. G., Murray, T. G., Moric, M., Sporer, S. M., Paprosky, W. G.,
and Della Valle, C. J.: Risk factors for dislocation after revision total
hip arthroplasty hip, Clin. Orthop. Relat. Res., 471, 410–416,
https://doi.org/10.1007/s11999-012-2561-7, 2013.
Xie, Y., He, Y., Irwin, P. L., Jin, T., and Shi, X.: Antibacterial activity
and mechanism of action of zinc oxide nanoparticles against Campylobacter
jejuni, Appl. Environ. Microbiol., 77, 2325–2331,
https://doi.org/10.1128/AEM.02149-10, 2011.
Xiong, L., Pan, Q., Jin, G., Xu, Y., and Hirche, C.: Topical intrawound
application of vancomycin powder in addition to intravenous administration
of antibiotics: A meta-analysis on the deep infection after spinal
surgeries, Orthop. Traumatol. Surg. Res., 100, 785–789,
https://doi.org/10.1016/j.otsr.2014.05.022, 2014.
Zagra, L., Gallazzi, E., Romanò, D., Scarponi, S., and Romanò, C.:
Two-stage cementless hip revision for peri-prosthetic infection with an
antibacterial hydrogel coating: results of a comparative series, Int.
Orthop., 43, 111–115, https://doi.org/10.1007/s00264-018-4206-2, 2019.
Zajonz, D., Birke, U., Ghanem, M., Prietzel, T., Josten, C., Roth, A., and
Fakler, J. K. M.: Silver-coated modular Megaendoprostheses in salvage
revision arthroplasty after periimplant infection with extensive bone loss –
A pilot study of 34 patients, BMC Musculoskelet. Disord., 18, 383,
https://doi.org/10.1186/s12891-017-1742-7, 2017.
Zmistowski, B. and Casper, D. S.: Periprosthetic Joint Infection Increases
the Risk, J. Bone Joint Surg. Am., 95, 2177–2185, https://doi.org/10.2106/JBJS.L.00789, 2013.
